Coronary Artery Bypass Grafts Device Market Expected to Reach $1.38 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Coronary Artery Bypass Grafts Device Market," The global coronary artery bypass grafts device market was valued at $0.96 billion in 2022, and is projected to reach $1.38 billion by 2032, growing at a CAGR of 3.7% from 2023 to 2032.

Coronary artery bypass graft (CABG) devices are medical tools and equipment used in the surgical procedure known as coronary artery bypass grafting. This procedure is performed to treat coronary artery disease (CAD), a condition in which the blood vessels supplying blood to the heart muscle (coronary arteries) become narrowed or blocked by a buildup of plaque. Coronary artery bypass graft is generally recommended when there are high-grade blockages in any of the major coronary arteries and percutaneous coronary intervention (PCI) has failed to clear the blockages. 

The coronary artery bypass graft (CABG) devices market is expected to grow significantly owing to the surge in prevalence of cardiovascular diseases. This includes conditions such as heart disease, stroke, hypertension, and coronary artery disease. The rise in prevalence of coronary artery disease is attributed to the unhealthy lifestyle and the rise in geriatric population. Furthermore, the development of the healthcare system also contributes to the growth of the market. Expanding healthcare infrastructure, particularly in emerging markets, ensures that a larger population has access to cardiovascular healthcare services and treatments. 

The surge in the prevalence of cardiovascular diseases has emerged as a major driver for the growth of the coronary artery bypass graft (CABG) devices market. Cardiovascular diseases, includes conditions such as coronary artery disease, angina, and myocardial infarction, which continue to be a global health concern, accounting for a significant portion of morbidity and mortality rates. For instance, according to the American Heart Association, in 2020, coronary heart disease (CHD) was the leading cause (41.2%) of deaths attributable to cardiovascular diseases in the U.S., followed by stroke (17.3%), other CVD (16.8%), high blood pressure (12.9%), heart failure (9.2%), diseases of the arteries (2.6%). 

This alarming trend is attributed to a multitude of factors, including sedentary lifestyles, poor dietary habits, and an aging population. As these risk factors become increasingly prevalent, the demand for effective treatment options has soared, leading to a surge in coronary artery bypass graft procedures. Coronary artery bypass graft remains a gold standard intervention for patients with severe coronary artery disease, as it restores blood flow to the heart by bypassing obstructed arteries. Thus, the surge in the prevalence of cardiovascular diseases has emerged as a major driver for the growth of the coronary artery bypass graft (CABG) devices market. 

The development of healthcare infrastructure, surge in investments has emerged as a coronary artery bypass grafts device market trends propelling the growth. Advanced healthcare systems offer state-of-the-art diagnostic tools, surgical equipment, and post-operative care, which not only improve the quality of CABG procedures but also promote their adoption. Surgeons and patients alike benefit from cutting-edge technologies and facilities, such as catheterization labs and hybrid operating rooms, which require an array of specialized devices to perform CABG surgeries efficiently and effectively. Thus, the development of healthcare infrastructure emerged as a significant factor driving the growth of the coronary artery bypass graft (CABG) devices market. However, the high cost of coronary artery bypass graft surgery might restrain the growth of the market. 

On the basis of technology, the coronary artery bypass grafts device market analysis is classified into off-pump, on-pump, and minimally invasive CABG. The on-pump segment was the largest revenue contributor to the coronary artery bypass grafts device market size in 2022, owing to the high adoption of the on-pump technology as it provides blood less and stable field for surgery. However, off pump segment is expected to register the fastest growth in the coronary artery bypass grafts device market forecast owing to the reduced risk of complications during the surgery. 

On the basis of product, the market is classified into cardiopulmonary bypass machines, endoscopic vessel harvesting systems, heart positioners, tissue stabilizer, and others. The tissue stabilizer segment was the highest revenue contributor to the coronary artery bypass grafts device market size in 2022 owing to high use of tissue stabilizer to ensure the proper stable surgical field. However, the endoscopic vessel harvesting segment is expected to register the fastest growth in the forecasted period owing to high adoption surgical field due to enhanced visualization and minimalist approach.

On the basis of end user, the market is classified into hospitals, cardiology centers, and others. The hospital segment was the largest revenue contributor to the coronary artery bypass grafts device market share in 2022, owing to the high number of coronary artery bypass graft surgeries performed in the hospitals. However, cardiology clinics is expected to register the fastest growth during the forecasted period owing to the cost effectivity of cardiology clinics and specialized treatment. 

On the basis of region, North America has the highest coronary artery bypass grafts device market share in 2022, and is expected to maintain its lead during the forecast period, owing to rise in geriatric population, strong presence of major key players and well-developed healthcare infrastructure. However, Asia-Pacific is coronary artery bypass grafts device industry expected to exhibit the fastest growth during the forecast period, owing to a rise in the prevalence of heart and circulatory diseases. 

Key Findings of the Study 

• On the basis of technology, the on-pump segment was the highest contributor to the market in 2022. However, off pump segment is expected to register the fastest growth during the forecasted period. 
• On the basis of product, the tissue stabilizer was the highest contributor to the coronary artery bypass grafts device industry in 2022. 
• On the basis of end user, the hospital segment was the highest contributor to the market in 2022. 
• On the basis of region, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.